Is the Fourth Time the Charm for This Antidepressant?
An FDA advisory committee is considering the fate of gepirone, which was rejected by the agency in 2002, 2004, and 2007.
All articles by Jonathan Block
Parental Death In Childhood Raises Suicide Risk
Suicide risk may be strongly influenced by events that happen early in life.
Faulty Brain Cells Implicated As Possible Depression Cause
Malfunctioning microglia can cause depression, but drugs that restore the normal functioning of them can be as effective as antidepressants.
CBT Program Benefits Youth At Risk for Depression For Years
Teens who had one parent with depression who took part in a cognitive-behavioral prevention program were less likely to develop depression.
APA Asks Federal, State Officials to Examine Anthem, Cigna Merger
The APA is concerned that the merger will strengthen the insurers’ buying power of psychiatric services to patients’ detriment.
Males, Females With Autism Score Same on Inference Test
Results bolster the “extreme male brain” theory of autism.
Shortage of Psychiatrists Only Getting Worse
From 1995 to 2013, the number of psychiatrists in the U.S. increased by just 12%.
Mindfulness As Effective As Antidepressants For Depression Relapse
Mindfulness group treatment may also be cheaper than antidepressant therapy which is provided on an individual basis.
Long-Acting Antipsychotic Delays Schizophrenia Relapse Longer Than Pills
Invega Sustenna, which is given once per month, delayed relapse of schizophrenia longer than commonly prescribed oral antipsychotics.
Senate Passes Bill Repealing SGR Payment Formula
President Obama is expected to sign the legislation, which puts an end to short-term fixes and provides for Medicare payment reforms.
Next post in Practice Management
